Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition

Author:

Harris P.N.A.,McNamara J.F.,Lye D.C.,Davis J.S.,Bernard L.,Cheng A.C.,Doi Y.,Fowler V.G.,Kaye K.S.,Leibovici L.,Lipman J.,Llewelyn M.J.,Munoz-Price S.,Paul M.,Peleg A.Y.,Rodríguez-Baño J.,Rogers B.A.,Seifert H.,Thamlikitkul V.,Thwaites G.,Tong S.Y.C.,Turnidge J.,Utili R.,Webb S.A.R.,Paterson D.L.

Funder

NIH

MedImmune

Forest/Cerexa

Pfizer

Merck

Advanced Liquid Logics

Theravance

Novartis

Cubist

AstraZeneca

University of Queensland

National Institutes of Health

National Institute of Allergy and Infectious Diseases (NIAID)

Australian National Health and Medical Research Council Career Development Fellowship

German Centre for Infection Research (DZIF), Germany

Ministerio de Economía y Competitividad, Instituto de Salud Carlos III

European Development Regional Fund ‘A way to achieve Europe' ERDF

Innovatives Medicine Initiative (IMI)

European Union's Seventh Framework Programme

EFPIA

European Union 7th Framework Programme

NHMRC Career Development Fellowship

NHMRC

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference51 articles.

1. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe;Goto;Clin Microbiol Infect,2013

2. Infectious diseases consultations at an Australian tertiary hospital: a review of 11,511 inpatient consultations;Bursle;Intern Med J,2014

3. What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore;Ingram;Clin Microbiol Infect,2014

4. The Delphi Technique: making sense of consensus;Hsu;Pract Assess Res Eval,2007

5. A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study;Dulhunty;Crit Care Resusc,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3